MGMT and glioblastoma: Epigenetic silencing of the MGMT gene by promoter methylation is associated with loss of MGMT expression [4-6], diminished DNA-repair activity and longer overall survival in patients with glioblastoma (GBM) who, in addition to radiotherapy, received alkylating chemotherapy with temozolomide [7].